Anyone else here in San Francisco for this?
So far the talks have been quite good, I think. If anyone's interested but can't attend, I'm blogging some of it at Mendelian Disorder.
In short, the presenters were clearly hand-picked because they've got strong findings using CGI. I want to also say that it's good to see some genuine academics presenting here... people using RealTimeGenomics for analysis, people pairing the CG data with exome-seq off an Illumina, et cetera. I do have to say that a lot of the findings seem to be stuff that can be identified solely through exome-seq, which makes one wonder why they would invest in whole genome sequencing. That said, for the sake of copy number, SVs, et cetera in cancer genomes it makes sense to go with whole genome.
So far the talks have been quite good, I think. If anyone's interested but can't attend, I'm blogging some of it at Mendelian Disorder.
In short, the presenters were clearly hand-picked because they've got strong findings using CGI. I want to also say that it's good to see some genuine academics presenting here... people using RealTimeGenomics for analysis, people pairing the CG data with exome-seq off an Illumina, et cetera. I do have to say that a lot of the findings seem to be stuff that can be identified solely through exome-seq, which makes one wonder why they would invest in whole genome sequencing. That said, for the sake of copy number, SVs, et cetera in cancer genomes it makes sense to go with whole genome.
Comment